drugset / Trial / NCT02729441

Perindopril vs Ramipril for Persistence in MAU Reduction Study

NCT02729441

RandomizedCrossoverOpen-labelTreatment

Summary

The investigators conducted a single center study controlled study involving 20 patients with Type 2 Diabetes and hypertension who were randomly assigned to receive ramipril 10mg or perindopril 8mg. The primary endpoint was difference in urine albumin-creatinine ratio at night time and during the day. Secondary endpoint was measurement of blood pressure.

Timeline

Start
2010-04
Primary completion
2012-08
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Perindopril Small molecule 8 mg
Comparator Ramipril Small molecule 10 mg